Florencia Laciar

Florencia Laciar

Auto-generated profile, based on publicly available information

Florencia Laciar

Section of Graduate Periodontology, Department of Dental Clinic Specialties, Faculty of Dentistry, Complutense University of Madrid, 28040 Madrid, Spain

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2023 in Applied Sciences
Verified
Journal Article
Open access
PDF file
VVViviane Lopes Vasconcelos
Viviane Lopes Vasconcelos
FLFlorencia Laciar
Florencia Laciar
PMPaula Matesanz
Paula Matesanz
MIMargarita Iniesta
Margarita Iniesta
BABettina Alonso
Bettina Alonso
David HerreraDavid Herrera
David Herrera
The primary objective was to assess the safety of a new toothpaste formulation containing cetylpyridinium chloride (CPC) and cymenol as active agents. In addition, clinical efficacy and patient perception were evaluated. A 6-week randomized clinical trial was designed and patients were randomly allocated to use a test or control dentifrice. Adverse effects were assessed at 3- and 6-week follow-up visits, together with the following clinical parameters: Turesky plaque index (PlI), bleeding on marginal probing (BOMP), bleeding on probing (BOP) and Gründemann modification of the stain index (GMSI). Patient-reported outcome measures (PROMs) were also evaluated. A total of 60 patients were randomized and 55 were finally included in the analysis (test, 29; control, 26). Both toothpastes were safe and well tolerated by the patients. Statistically significant differences between test and control groups were observed for BOP changes between baseline week 6 (p = 0.031) and lower levels of plaque were registered in the test group at the 3- and 6-week visits (p < 0.05). No differences were observed for staining or PROMs. The use of a toothpaste containing CPC and cymenol was safe and not associated with any adverse effects. Significantly better clinical results were observed for the test group in terms of PlI levels and BOP reductions.